Triple-negative breast cancer (TNBC) is an extremely hard-to-treat subtype (~15%) of breast cancer. As TNBC lacks expression of human epidermal growth factor 2 (HER2), estrogen receptor (ER), and progesterone receptor (PR), traditional small-molecule inhibitors of therapeutic targets have little/no ...

On December 6, 2018, Professor Jianxin Wang and Associate Professor Zhiqing Pang from Department of Pharmaceutics, School of Pharmacy, Fudan University jointly published a research paper entitled "Route to Rheumatoid Arthritis by Macrophage-Microvesicle-Coated Nanoparticles" in Nano Letters (IF=12.0...

On December 1, 2018, the 12th China Pharmaceutical Conference was successfully held in Guangzhou. The conference was sponsored by the Chinese Pharmaceutical Association (CPA), the Pharmaceutics Professional Committee of CPA, the China Chapter of the Controlled Release Society (CRS) and the School of...

Sphingomyelin (SM) is the main component of phospholipids, which serve as central regulators in various physiological pathways such as cell proliferation, cell death and apoptosis, and intracellular trafficking. SM distributes mainly in the membrane and is synthesized by sphingomyelin synthase 1/2 (...

Recently, news released from the State Drug Administration (SFDA) that the innovative small molecule drug with new mechanism, leonurine sulfate tablets (referred to as “SCM-198”) which was previously transferred to Zhongzhu Medical, has been approved by the SFDA for clinical trial. The Approval (N...

Recently, winners of the ‘2017 Fudan University Teaching and Learning Awards’were announced. The Innovations in Talent Management Model in Clinical Pharmacy finished by School of Pharmacy was awarded the first prize (participants included HOU Aijun, CAI Weimin, MA Guo, LV Qianzhou, ZHONG Mingkang,...

Cystathionine b-synthase (CBS) deficiency results in homocysteinuria, a rare genetic disorder characterized by a constellation of symptoms ranging from developmental delay to thromboembolism and megaloblastic anemia. Given that products of CBS metabolism interact with interlukin-6 (IL-6), a major de...

The scientific research achievement of our School, “Research on brain tumor-targeted drug delivery”, won the Second Prize of Shanghai Natural Science Award (2016) and the Second Prize of Excellent Achievements in Scientific Research in Universities (2016). This achievement was accomplished by Prof...

After over 10 years of hard working, the research team led by Prof. Yizhun Zhu from School of Pharmacy of Fudan University has extracted leonurine (also known as SCM-198) from the Chinese herbal medicine Motherwort with obvious curative effect on stroke.

The 1st Competition of Achievements in Industry, Research, Education and Medicine for Health and Nanotechnology was held on Dec 9, 2016 in Shanghai. More than 170 projects participated in this competition. Professor Weiyue Lu of Department of Pharmaceutics was invited to give a speech in the summit ...

With rapid population aging and the prevalence of electronics, diseases in fundus oculi, such as age-related macular degeneration and proliferative diabetic retinopathy, have been the leading cause of blindness worldwide. For example, age-related macular degeneration incidence is about 8% in people ...